Gilead Sciences to close Seattle office
Gilead lays off 72 workers in Seattle, plans to shutter R&D support site
Roughly a year ago, Gilead Sciences revealed that it was laying off about 7% of Kite Pharma’s workforce in a bid to refresh its cell therapy subsidiary. | Gilead will lay off 72 staffers in Seattle, the company confirmed Thursday.
COVID drugmaker to close Seattle office, laying off 72 workers
Gilead Sciences, a biopharma giant known for developing COVID-19 and HIV/AIDS treatments, is closing its Seattle office, according to a state filing on Wednesday. The Washington State Employment Security Department said in the filing that 72 employees will be laid off on Jan.
Hosted on MSN20h
Gilead Sciences, Inc. (GILD) is Attracting Investor Attention: Here is What You Should KnowGilead Sciences (GILD) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.
Wolfe Research initiated coverage of Gilead (GILD) with an Outperform rating and $110 price target Gilead’s bread and butter has been ...
Zacks.com on MSN19h
Brokers Suggest Investing in Gilead (GILD): Read This Before Placing a BetWhen deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often ...
Despite a robust HIV portfolio and growing oncology sales, Gilead struggles to diversify revenue streams significantly. Learn ...
Wolfe Research initiated coverage of Gilead (GILD) with an Outperform rating and $110 price target Published first on TheFly – the ...
Gilead Sciences ( GILD) increased its growth forecast for the year on strong third quarter results, marking a shift away from ...
"The first question he asked was did the team win," Mount Gilead head coach Jake Hayes said of his now four-time All-Ohioan ...
OBETZ — Mount Gilead's boys cross country team has enjoyed a decade of dominance unlike any high school sports program in the Marion area. Saturday was another link in the chain when MG won the ...
(This story was updated to accurately reflect the most current information.) OBETZ — Mount Gilead left nothing to chance ...
Citi has started coverage of Gilead Sciences (NASDAQ:GILD) and Vertex Pharmaceuticals (NASDAQ:VRTX) at buy saying the former will benefit from short-term growth of Biktarvy (bictegravir, emtricitabine ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback